Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

NEXT GEN - PHILIPS OPTIMUS

NCT: NCT07521735 · COMPLETED

NCT IDNCT07521735
StatusCOMPLETED
Start Date2026-03-09
Completion2026-03-31
SponsorPhilips Clinical & Medical Affairs Global (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this clinical study is to validate the SpO2 accuracy performance of the sponsor's SpO2 sensors over the range of 70-100% SaO2 during non-motion conditions assessed by CO-Oximetry.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑